Immune System and Postmenopausal Bone Loss

Clinical Reviews in Bone and Mineral Metabolism

Volumn 7, Issue 4, 2009, Pages 262-268

  D'Amelio, Patrizia ^a   Isaia, Giovanni Carlo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

B cells; Cytokines; Estrogen; Menopause; Osteoclast; Osteoporosis; T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CYTOKINE PRODUCTION; ESTROGEN DEFICIENCY; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 70449526546     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12018-009-9061-7     Document Type: Review

References (77)

1. GR Mundy 2007 Osteoporosis and inflammation Nutr Rev 65 S147 S151 10.1111/j.1753-4887.2007.tb00353.x 18240539
2. N Horwood 2008 Lymphocyte-derived cytokines in inflammatory arthritis Autoimmunity 41 230 238 10.1080/08916930701694766 18365837
3. MN Weitzmann R Pacifici 2007 T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis Ann N Y Acad Sci 1116 360 375 10.1196/annals.1402.068 18083938 (Pubitemid 350274346)
4. RH Straub 2007 The complex role of estrogens in inflammation Endocr Rev 28 521 574 10.1210/er.2007-0001 17640948 (Pubitemid 47236336)
5. SL Teitelbaum 2004 Postmenopausal osteoporosis, T cells, and immune dysfunction Proc Natl Acad Sci U S A 101 16711 16712 10.1073/pnas.0407335101 15557556 (Pubitemid 39601302)
6. L Rifas S Arackal 2003 T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism Arthritis Rheum 48 993 1001 10.1002/art.10872 12687541 (Pubitemid 36418241)
7. S Kotake N Udagawa M Hakoda M Mogi K Yano E Tsuda K Takahashi T Furuya S Ishiyama KJ Kim S Saito T Nishikawa N Takahashi A Togari T Tomatsu T Suda N Kamatani 2001 Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients Arthritis Rheum 44 1003 1012 10.1002/1529-0131(200105)44: 5<1003::AID-ANR179>3.0.CO;2-# 11352231 (Pubitemid 32433604)
8. S Colucci G Brunetti R Rizzi A Zonno G Mori G Colaianni D Del Prete R Faccio A Liso S Capalbo V Liso A Zallone M Grano 2004 T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction Blood 104 3722 3730 10.1182/blood-2004-02-0474 15308561 (Pubitemid 39564450)
9. G Brunetti S Colucci P Pignataro M Coricciati G Mori N Cirulli A Zallone FR Grassi M Grano 2005 T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients J Periodontol 76 1675 1680 10.1902/jop.2005.76.10.1675 16253089 (Pubitemid 41645576)
10. I Roato G Brunetti E Gorassini M Grano S Colucci L Bonello L Buffoni R Manfredi E Ruffini D Ottaviani L Ciuffreda A Mussa R Ferracini 2006 IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor PLoS One 1 e124 10.1371/journal.pone.0000124 17205128
11. I Roato M Grano G Brunetti S Colucci A Mussa O Bertetto R Ferracini 2005 Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement FASEB J 19 228 230 15550550
12. P D'Amelio A Grimaldi S Di Bella SZ Brianza MA Cristofaro C Tamone G Giribaldi D Ulliers GP Pescarmona G Isaia 2008 Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis Bone 43 92 100 10.1016/j.bone.2008.02.017 18407820
13. P D'Amelio A Grimaldi GP Pescarmona C Tamone I Roato G Isaia 2005 Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis FASEB J 19 410 412 15611151
14. G Eghbali-Fatourechi S Khosla A Sanyal WJ Boyle DL Lacey BL Riggs 2003 Role of RANK ligand in mediating increased bone resorption in early postmenopausal women J Clin Invest 111 1221 1230 12697741
15. S Khosla 2001 Minireview: the OPG/RANKL/RANK system Endocrinology 142 5050 5055 10.1210/en.142.12.5050 11713196 (Pubitemid 33131929)
16. YY Kong H Yoshida I Sarosi HL Tan E Timms C Capparelli S Morony AJ Oliveira-dos-Santos G Van A Itie W Khoo A Wakeham CR Dunstan DL Lacey TW Mak WJ Boyle JM Penninger 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 315 323 10.1038/16852 9950424 (Pubitemid 29061638)
17. T Suda N Takahashi N Udagawa E Jimi MT Gillespie TJ Martin 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr Rev 20 345 357 10.1210/er.20.3.345 10368775 (Pubitemid 30649812)
18. LC Hofbauer S Khosla CR Dunstan DL Lacey WJ Boyle BL Riggs 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J Bone Miner Res 15 2 12 10.1359/jbmr.2000.15.1.2 10646108
19. H Yasuda N Shima N Nakagawa K Yamaguchi M Kinosaki S Mochizuki A Tomoyasu K Yano M Goto A Murakami E Tsuda T Morinaga K Higashio N Udagawa N Takahashi T Suda 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci U S A 95 3597 3602 10.1073/pnas.95.7.3597 9520411 (Pubitemid 28173173)
20. NJ Horwood V Kartsogiannis JM Quinn E Romas TJ Martin MT Gillespie 1999 Activated T lymphocytes support osteoclast formation in vitro Biochem Biophys Res Commun 265 144 150 10.1006/bbrc.1999.1623 10548505
21. H Hotokezaka E Sakai N Ohara Y Hotokezaka C Gonzales K Matsuo Y Fujimura N Yoshida K Nakayama 2007 Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan J Cell Biochem 101 122 134 10.1002/jcb.21167 17171644 (Pubitemid 46652578)
22. J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum 2000 TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand J Clin Invest 106 1481 1488 10.1172/JCI11176 11120755
23. C Roggia Y Gao S Cenci MN Weitzmann G Toraldo G Isaia R Pacifici 2001 Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo Proc Natl Acad Sci U S A 98 13960 13965 10.1073/pnas.251534698 11717453 (Pubitemid 33116006)
24. R Pacifici C Brown E Puscheck E Friedrich E Slatopolsky D Maggio R McCracken LV Avioli 1991 Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells Proc Natl Acad Sci U S A 88 5134 5138 10.1073/pnas.88.12.5134 2052592
25. N Charatcharoenwitthaya S Khosla EJ Atkinson LK McCready BL Riggs 2007 Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women J Bone Miner Res 22 724 729 10.1359/jbmr.070207 17295604 (Pubitemid 351339101)
26. D Diarra M Stolina K Polzer J Zwerina MS Ominsky D Dwyer A Korb J Smolen M Hoffmann C Scheinecker D van der Heide R Landewe D Lacey WG Richards G Schett 2007 Dickkopf-1 is a master regulator of joint remodeling Nat Med 13 156 163 10.1038/nm1538 17237793 (Pubitemid 46245765)
27. SX Zheng Y Vrindts M Lopez D De Groote PF Zangerle J Collette N Franchimont V Geenen A Albert JY Reginster 1997 Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis Maturitas 26 63 71 10.1016/S0378-5122(96)01080-8 9032749 (Pubitemid 27063783)
28. SJ Vargas A Naprta M Glaccum SK Lee J Kalinowski JA Lorenzo 1996 Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor J Bone Miner Res 11 1736 1744 8915781
29. RB Kimble JL Vannice DC Bloedow RC Thompson W Hopfer VT Kung C Brownfield R Pacifici 1994 Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats J Clin Invest 93 1959 1967 10.1172/JCI117187 8182127 (Pubitemid 24143073)
30. R Kitazawa RB Kimble JL Vannice VT Kung R Pacifici 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice J Clin Invest 94 2397 2406 10.1172/JCI117606 7989596
31. S Wei H Kitaura P Zhou FP Ross SL Teitelbaum 2005 IL-1 mediates TNF-induced osteoclastogenesis J Clin Invest 115 282 290 15668736
32. G Toraldo C Roggia WP Qian R Pacifici MN Weitzmann 2003 IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells Proc Natl Acad Sci U S A 100 125 130 10.1073/pnas.0136772100 12490655 (Pubitemid 36078040)
33. MN Weitzmann S Cenci L Rifas C Brown R Pacifici 2000 Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines Blood 96 1873 1878 10961889
34. C Miyaura Y Onoe M Inada K Maki K Ikuta M Ito T Suda 1997 Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency Proc Natl Acad Sci U S A 94 9360 9365 10.1073/pnas.94.17.9360 9256487 (Pubitemid 27357834)
35. KL Komschlies TT Back TA Gregorio ME Gruys G Damia RH Wiltrout CR Faltynek 1994 Effects of rhIL-7 on leukocyte subsets in mice: implications for antitumor activity Immunol Ser 61 95 104 8011760
36. P D'Amelio A Grimaldi P Bernabei GP Pescarmona G Isaia 2006 Immune system and bone metabolism: does thymectomy influence postmenopausal bone loss in humans? Bone 39 658 665 10.1016/j.bone.2006.03.009 16690366 (Pubitemid 44149278)
37. N Giuliani S Colla R Sala M Moroni M Lazzaretti S La Monica S Bonomini M Hojden G Sammarelli S Barille R Bataille V Rizzoli 2002 Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease Blood 100 4615 4621 10.1182/blood-2002-04-1121 12393684 (Pubitemid 35429706)
38. T Sato K Watanabe M Masuhara N Hada Y Hakeda 2007 Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro J Bone Miner Metab 25 19 27 10.1007/s00774-006-0723-y 17187190 (Pubitemid 46012993)
39. SK Lee JF Kalinowski SL Jastrzebski L Puddington JA Lorenzo 2003 Interleukin-7 is a direct inhibitor of in vitro osteoclastogenesis Endocrinology 144 3524 3531 10.1210/en.2002-221057 12865334 (Pubitemid 36904431)
40. SK Lee JF Kalinowski C Jacquin DJ Adams G Gronowicz JA Lorenzo 2006 Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss J Bone Miner Res 21 695 702 10.1359/jbmr.060117 16734384
41. S Colucci G Brunetti FP Cantatore A Oranger G Mori L Quarta N Cirulli L Mancini A Corrado FR Grassi M Grano 2007 Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis J Pathol 212 47 55 10.1002/path.2153 17370327 (Pubitemid 46746289)
42. I Roato E Gorassini G Brunetti M Grano L Ciuffreda A Mussa R Ferracini 2007 IL-7 modulates osteoclastogenesis in patients affected by solid tumors Ann N Y Acad Sci 1117 377 384 10.1196/annals.1402.002 17584976 (Pubitemid 350191262)
43. I Roato P D'Amelio E Gorassini A Grimaldi L Bonello C Fiori L Delsedime A Tizzani A De Libero G Isaia R Ferracini 2008 Osteoclasts are active in bone forming metastases of prostate cancer patients PLoS One 3 e3627 10.1371/journal.pone.0003627 18978943
44. S Gendron M Boisvert N Chetoui F Aoudjit 2008 Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function Immunology 125 359 369 10.1111/j.1365-2567.2008.02858.x 18479350
45. H Takayanagi K Ogasawara S Hida T Chiba S Murata K Sato A Takaoka T Yokochi H Oda K Tanaka K Nakamura T Taniguchi 2000 T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma Nature 408 600 605 10.1038/35046102 11117749
46. K Sato T Satoh K Shizume Y Yamakawa Y Ono H Demura T Akatsu N Takahashi T Suda 1992 Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice Cancer Res 52 444 449 1728416
47. K Vermeire H Heremans M Vandeputte S Huang A Billiau P Matthys 1997 Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice J Immunol 158 5507 5513 9164974 (Pubitemid 127681260)
48. Y Gao F Grassi MR Ryan M Terauchi K Page X Yang MN Weitzmann R Pacifici 2007 IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation J Clin Invest 117 122 132 10.1172/JCI30074 17173138 (Pubitemid 46048459)
49. S Cenci G Toraldo MN Weitzmann C Roggia Y Gao WP Qian O Sierra R Pacifici 2003 Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator Proc Natl Acad Sci U S A 100 10405 10410 10.1073/pnas.1533207100 12923292 (Pubitemid 37071891)
50. J Arnoldi J Gerdes HD Flad 1990 Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy Am J Pathol 137 749 753 2121040 (Pubitemid 20337789)
51. GS Firestein JM Alvaro-Gracia R Maki 1990 Quantitative analysis of cytokine gene expression in rheumatoid arthritis J Immunol 144 3347 3353 2109776
52. GW Cannon SH Pincus RD Emkey A Denes SA Cohen F Wolfe PA Saway AM Jaffer AL Weaver L Cogen, et al. 1989 Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis Arthritis Rheum 32 964 973 10.1002/anr.1780320805 2504171
53. EM Veys CJ Menkes P Emery 1997 A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis Arthritis Rheum 40 62 68 10.1002/art.1780400110 9008601 (Pubitemid 27044037)
54. GN Mann TW Jacobs FJ Buchinsky EC Armstrong M Li HZ Ke YF Ma WS Jee S Epstein 1994 Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia Endocrinology 135 1077 1083 10.1210/en.135.3.1077 8070349
55. LL Key Jr RM Rodriguiz SM Willi NM Wright HC Hatcher DR Eyre JK Cure PP Griffin WL Ries 1995 Long-term treatment of osteopetrosis with recombinant human interferon gamma N Engl J Med 332 1594 1599 10.1056/NEJM199506153322402 7753137
56. H Takayanagi S Kim T Taniguchi 2002 Signaling crosstalk between RANKL and interferons in osteoclast differentiation Arthritis Res 4 Suppl 3 S227 S232 10.1186/ar581 12110142
57. JH Cohen L Danel G Cordier S Saez JP Revillard 1983 Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells J Immunol 131 2767 2771 6605988
58. L Danel G Souweine JC Monier S Saez 1983 Specific estrogen binding sites in human lymphoid cells and thymic cells J Steroid Biochem 18 559 563 10.1016/0022-4731(83)90131-0 6855231
59. N Kanda K Tamaki 1999 Estrogen enhances immunoglobulin production by human PBMCs J Allergy Clin Immunol 103 282 288 10.1016/S0091-6749(99)70503-8 9949320
60. D Verthelyi SA Ahmed 1994 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice Endocrinology 135 2615 2622 10.1210/en.135.6.2615 7988450 (Pubitemid 24377423)
61. T Masuzawa C Miyaura Y Onoe K Kusano H Ohta S Nozawa T Suda 1994 Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow J Clin Invest 94 1090 1097 10.1172/JCI117424 8083350
62. N Manabe H Kawaguchi H Chikuda C Miyaura M Inada R Nagai Y Nabeshima K Nakamura AM Sinclair RH Scheuermann M Kuro-o 2001 Connection between B lymphocyte and osteoclast differentiation pathways J Immunol 167 2625 2631 11509604
63. J An RC Ribeiro P Webb JA Gustafsson PJ Kushner JD Baxter DC Leitman 1999 Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators Proc Natl Acad Sci U S A 96 15161 15166 10.1073/pnas.96.26.15161 10611355 (Pubitemid 30019782)
64. NN Yang M Venugopalan S Hardikar A Glasebrook 1996 Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene Science 273 1222 1225 10.1126/science.273.5279.1222 8703055
65. VR Porter GA Greendale M Schocken X Zhu RB Effros 2001 Immune effects of hormone replacement therapy in post-menopausal women Exp Gerontol 36 311 326 10.1016/S0531-5565(00)00195-9 11226745 (Pubitemid 32162484)
66. U Stopinska-Gluszak J Waligora T Grzela M Gluszak J Jozwiak D Radomski PI Roszkowski J Malejczyk 2006 Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women J Reprod Immunol 69 65 75 10.1016/j.jri.2005.07.006 16236362 (Pubitemid 43144472)
67. TS Heng GL Goldberg DH Gray JS Sutherland AP Chidgey RL Boyd 2005 Effects of castration on thymocyte development in two different models of thymic involution J Immunol 175 2982 2993 16116185
68. JS Sutherland GL Goldberg MV Hammett AP Uldrich SP Berzins TS Heng BR Blazar JL Millar MA Malin AP Chidgey RL Boyd 2005 Activation of thymic regeneration in mice and humans following androgen blockade J Immunol 175 2741 2753 16081852
69. M Ramnaraine W Pan DR Clohisy 2006 Osteoclasts direct bystander killing of cancer cells in vitro Bone 38 4 12 10.1016/j.bone.2005.07.016 16139579 (Pubitemid 43006069)
70. HM Massey AM Flanagan 1999 Human osteoclasts derive from CD14-positive monocytes Br J Haematol 106 167 170 10.1046/j.1365-2141.1999.01491.x 10444181 (Pubitemid 29343545)
71. V Shalhoub G Elliott L Chiu R Manoukian M Kelley N Hawkins E Davy G Shimamoto J Beck SA Kaufman G Van S Scully M Qi M Grisanti C Dunstan WJ Boyle DL Lacey 2000 Characterization of osteoclast precursors in human blood Br J Haematol 111 501 512 10.1046/j.1365-2141.2000.02379.x 11122091 (Pubitemid 32010753)
72. S Cenci MN Weitzmann C Roggia N Namba D Novack J Woodring R Pacifici 2000 Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha J Clin Invest 106 1229 1237 10.1172/JCI11066 11086024
73. MN Weitzmann R Pacifici 2005 The role of T lymphocytes in bone metabolism Immunol Rev 208 154 168 10.1111/j.0105-2896.2005.00324.x 16313347 (Pubitemid 41746391)
74. D Grcevic SK Lee A Marusic JA Lorenzo 2000 Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1, 25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis J Immunol 165 4231 4238 11035056
75. D Grcevic IK Lukic N Kovacic S Ivcevic V Katavic A Marusic 2006 Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos Clin Exp Immunol 146 146 158 10.1111/j.1365-2249.2006. 03181.x 16968409 (Pubitemid 44393849)
76. SK Lee Y Kadono F Okada C Jacquin B Koczon-Jaremko G Gronowicz DJ Adams HL Aguila Y Choi JA Lorenzo 2006 T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy J Bone Miner Res 21 1704 1712 10.1359/jbmr.060726 17002560 (Pubitemid 46141225)
77. R Senthilkumar HW Lee 2009 CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation Immunobiology 214 153 161 10.1016/j.imbio.2008.05.001 19167994